From: Ab interno gel implant in patients with primary open angle glaucoma and pseudoexfoliation glaucoma
POAG (n = 67) | PEXG (n = 43) | |
---|---|---|
Age (years), mean ± SD (range) | 69.6 ± 13.7 (34–91) | 74.0 ± 8.3 (51–89) |
Gender, n (%) | ||
Male | 26 (38.8) | 20 (46.5) |
Female | 41 (61.2) | 23 (53.5) |
Operated Eye, n (%) | ||
OD (right eye) | 39 (58.2) | 22 (51.2) |
OS (left eye) | 28 (41.8) | 21 (48.8) |
Cup to Disc Ratio, mean ± SD (range) | 0.82 ± 0.13 (0.4–1.0) | 0.80 ± 0.10 (0.6–1.0) |
Lens status, n (%) | ||
Phakic | 62 (92.5%) | 39 (90.7%) |
Pseudophakic | 5 (7.5%) | 4 (9.3%) |
Prior glaucoma intervention, n (%) | ||
none | 22 (32.8%) | 14 (32.6%) |
Trabeculectomy | 13 (19.4%) | 6 (14.0%) |
Laser | 4 (6.0%) | 0 (0.0%) |
CPC | 13 (19.4%) | 6 (14.0%) |
Microstenta | 10 (14.9%) | 13 (30.2%) |
Phacoemulsification | 5 (7.5%) | 4 (9.3%) |
IOP (mmHg), mean ± SD (range) | 31.85 ± 8.5 (20–65) | 31.63 ± 9.0 (20–59) |
Number of medication, mean ± SD (range) | 3.25 ± 0.8 (2–5) | 3.05 ± 1.0 (0–5) |